SCL Science Inc. (KOSDAQ:246960)
South Korea · Delayed Price · Currency is KRW 2,175.00
-25.00 (-1.14%)
At close: Apr 2, 2026
SCL Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 22,011 | 4,737 | 1,322 | 369.78 | 507.29 |
Other Revenue | - | - | -0 | -0 | - |
| 22,011 | 4,737 | 1,322 | 369.78 | 507.29 | |
Revenue Growth (YoY) | 364.64% | 258.30% | 257.54% | -27.11% | -14.91% |
Cost of Revenue | 17,810 | 2,928 | 1,114 | 301.37 | 323.79 |
Gross Profit | 4,201 | 1,809 | 208.41 | 68.41 | 183.49 |
Selling, General & Admin | 4,730 | 3,301 | 2,662 | 3,037 | 3,092 |
Research & Development | 1,882 | 1,663 | 1,235 | 1,338 | 1,423 |
Amortization of Goodwill & Intangibles | 255.13 | 74.27 | 68.48 | 72.34 | 71.7 |
Operating Expenses | 7,599 | 5,469 | 4,226 | 4,673 | 4,721 |
Operating Income | -3,398 | -3,661 | -4,017 | -4,605 | -4,538 |
Interest Expense | -2,119 | -261.34 | -730.77 | -874.14 | -564.67 |
Interest & Investment Income | 275 | 129.95 | 141.07 | 170.34 | 99.68 |
Earnings From Equity Investments | -24.06 | - | -2,988 | -67.31 | 217.1 |
Currency Exchange Gain (Loss) | 0.14 | 9.42 | -9.53 | -7.42 | 1.74 |
Other Non Operating Income (Expenses) | 580 | 50.15 | 2,860 | -567.49 | -234.68 |
EBT Excluding Unusual Items | -4,686 | -3,733 | -4,744 | -5,951 | -5,019 |
Gain (Loss) on Sale of Investments | 21.3 | - | - | - | 29.8 |
Gain (Loss) on Sale of Assets | 62.09 | 40.88 | -63.87 | 0.02 | -10.38 |
Asset Writedown | -168.43 | -37.83 | -215.19 | -33.34 | -14.21 |
Pretax Income | -4,771 | -3,729 | -5,023 | -5,984 | -5,013 |
Income Tax Expense | -651.31 | 0.68 | 2.08 | -12.42 | 26.54 |
Earnings From Continuing Operations | -4,120 | -3,730 | -5,026 | -5,972 | -5,040 |
Minority Interest in Earnings | 185.32 | - | -0.72 | 0.1 | 10.74 |
Net Income | -3,934 | -3,730 | -5,026 | -5,972 | -5,029 |
Net Income to Common | -3,934 | -3,730 | -5,026 | -5,972 | -5,029 |
Shares Outstanding (Basic) | 33 | 29 | 25 | 21 | 20 |
Shares Outstanding (Diluted) | 33 | 29 | 25 | 21 | 20 |
Shares Change (YoY) | 12.50% | 15.96% | 18.93% | 4.73% | - |
EPS (Basic) | -120.00 | -128.00 | -200.01 | -282.61 | -249.26 |
EPS (Diluted) | -120.00 | -128.00 | -200.01 | -282.61 | -249.26 |
Free Cash Flow | -1,908 | -6,545 | -5,194 | -4,445 | -10,326 |
Free Cash Flow Per Share | -58.20 | -224.60 | -206.67 | -210.34 | -511.79 |
Gross Margin | 19.09% | 38.18% | 15.76% | 18.50% | 36.17% |
Operating Margin | -15.44% | -77.28% | -303.85% | -1245.36% | -894.52% |
Profit Margin | -17.87% | -78.74% | -380.17% | -1614.99% | -991.39% |
Free Cash Flow Margin | -8.67% | -138.17% | -392.84% | -1201.95% | -2035.58% |
EBITDA | -352.77 | -2,529 | -3,217 | -3,849 | -3,865 |
EBITDA Margin | -1.60% | -53.39% | -243.31% | - | - |
D&A For EBITDA | 3,045 | 1,132 | 800.4 | 756.35 | 673.08 |
EBIT | -3,398 | -3,661 | -4,017 | -4,605 | -4,538 |
EBIT Margin | -15.44% | -77.28% | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.